Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
The regulatory exposure in SOBR Safe SOBR results SOBR Safe Loss Widens on Strategic Spending SONY Sony Group Corporation American Depositary Shares posts narrow Q1 2026 EPS beat to lift shares 112 percent in todays trading Is NeoGenomics NEO stock forming lower lows Bullish Momentum 20260418 Alibaba Group Holding Ltd BABA Poised to Capture LongTerm Value Amid Escalating Chinese Generative AI Competition DoubleLine DLY Stock Market Trend Steady Climb 20260420 Is Chesapeake CPK stock an appealing investment opportunity Chesapeake posts 13 EPS miss revenue hits 930M Is Arrow AROW stock attractive at current levels Flatline 20260420 World WRLD Q1 2026 Results Fall Short EPS 770 Revenue NA MarketWise MKTW Q1 2026 Earnings Miss Sparks Concern BJs Rest BJRI Gains 081 Support Holds at 3996 20260515 SEMrush Holdings SEMR Stock Today Unchanged at 1200 Key Levels 20260514 AI Chip Supply Chain Under Strain as Iran Conflict Drives Material Costs Higher Wheeler WHLR Earnings Outlook Key Metrics for Q2 2024 Tata Motors PV Among Four NSE Stocks Flashing Bullish White Marubozu Pattern on May 27 Amazon UK Boss Criticises Education System Says Youth Unemployment Not Their Fault India Plans Major Tax Administration Overhaul to Ensure Smooth GST Rollout Jim Cramer Expresses Optimism on Palo Alto Networks PANW Amid Cybersecurity Sector Growth Top Economist Tyler Cowen Says AIs Biggest Challenge Is Adjustment Not Unemployment High Court Criticizes UOB Over Inconsistent Legal Positions on Mortgage Charges CRH Q1 2026 Earnings NarrowerThanExpected Loss Boosts Investor Sentiment IO Biotech Q3 2025 Earnings EPS Beat Highlights Cost Discipline Amid Ongoing Pipeline Development SRL Q4 2009 Earnings Massive EPS Beat Amidst Unusual Reporting Tetra Tech Inc Q1 2026 Earnings EPS Beat Driven by Strong Execution Amidst Uncertain Revenue Trajectory Protara Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss as Pipeline Advances DIS Q1 2026 Earnings EPS Beats Estimates by 437 Amid CostCutting and Streaming Progress Minerva Neurosciences NERV Edges Lower as Stock Tests Key Support Zone Edwards Lifesciences EW Slips 126 Amid Sector Headwinds Testing Key Support Levels Millrose Properties MRP Holds Steady Near Support as Consolidation Phase Emerges Smurfit WestRock SW Edges Higher as Support Holds Resistance Test Ahead National CineMedia NCMI Holds Steady Near 299 as Indecision Lingers